Regeneron Pharmaceuticals (NQ:REGN)
Price and Volume
Detailed Quote| Volume | 539,139 |
| Open | 956.28 |
| Bid (Size) | 973.84 (80) |
| Ask (Size) | 974.65 (120) |
| Prev. Close | 961.26 |
| Today's Range | 953.00 - 974.36 |
| 52wk Range | 591.52 - 974.00 |
| Shares Outstanding | 91,779,465 |
| Dividend Yield | 0.39% |
Top News
More News
Performance
52-Week Range
974.26
591.5252W Low
974.0052W High
1 Week
802.201W Low
974.001W High
Regeneron Pharmaceuticals (REGN) traded between $591.52 and $974.00 over the past 52 weeks and last traded at $974.26. Over the past week it ranged between $802.20 and $974.00.
Past 12 Months
+19.4%
+34.1%
+28.3%
+37.4%
+25.5%
+51.7%
1W
+$158.16
1M
+$247.79
3M
+$215.02
6M
+$265.05
YTD
+$197.95
1Y
+$332.01
REGN was +51.7% over the past year, +37.4% over six months, +25.5% year to date, +19.4% in the last week.
12 Months vs Market
REGN
+51.7%
DIA
+9.4%
SPY
+10.7%
QQQ
+8.8%
IWM
+14.5%
Over the past 12 months REGN returned +51.7% versus DIA (Dow) +9.4%, SPY (S&P 500) +10.7%, QQQ (Nasdaq 100) +8.8% and IWM (Russell 2000) +14.5%.
Volume & Liquidity
0.72× 3-mo avg
Today 539,139
3-mo avg 749.1K
1W
1.3M
1M
788.7K
3M
749.1K
6M
876.8K
YTD
827.0K
1Y
854.4K
REGN most recently traded 539,139 shares against a 3-month average daily volume of 749.1K.
More News
Read More
Regeneron Announces Investor Conference Presentations
November 02, 2026
Via GlobeNewswire
S&P 500 Unusual Volume Movers for Nov. 2, 2026 ↗
November 02, 2026
The top 5 analyst questions from Regeneron’s Q3 earnings call
November 01, 2026
Via StockStory
Topics
Earnings
Regeneron: 3 Key Takeaways for Long-Term Investors ↗
October 31, 2026
Via The Motley Fool
Topics
Earnings
Via StockStory
S&P 500 Top Movers: Gainers and Losers in Today's US Session ↗
October 30, 2026
S&P 500 Top Movers: Gainers and Losers in Today's Session ↗
October 30, 2026
Regeneron (REGN) stock trades up, here is why
October 30, 2026
Via StockStory
Topics
Artificial Intelligence
What Regeneron Pharmaceuticals (REGN) Said on Its Q3 Earnings Call ↗
October 30, 2026
Via MarketBeat
Regeneron (REGN) Q3 2026 Earnings Call Transcript ↗
October 30, 2026
Via The Motley Fool
Topics
Earnings
S&P 500 Premarket Gainers and Losers on Oct. 30, 2026 ↗
October 30, 2026
Regeneron (NASDAQ:REGN) surprises with strong Q3 2026, stock soars
October 30, 2026
Via StockStory
Regeneron Reports Third Quarter 2026 Financial and Operating Results
October 30, 2026
Via GlobeNewswire
What to expect from Regeneron’s (REGN) Q3 earnings
October 29, 2026
Via StockStory
Via StockStory
Q2 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
October 14, 2026
Via StockStory
Topics
Artificial Intelligence
Frequently Asked Questions
Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 974.26
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 11/03/26 01:47 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 89.42B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 89B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>